Table 4.
Baseline | LBNP | Δ (LBNP-Baseline) | ||||||
---|---|---|---|---|---|---|---|---|
Control (n=56) |
CFS (n=14) |
p- value* |
Control (n=56) |
CFS (n=14) |
Control (n=56) |
CFS (n=14) |
p- value* |
|
Variance (mmHg2) |
9.3 (8.4–12.4) |
12.7 (7.9–17.4) |
0.154 |
12.6 (10.2–13.7) |
12.0 (10.0–14.6) |
2.3 (0.4–4.7) |
2.0 (−1.2–3.5) |
0.333 |
Total Power (mmHg2) |
10.2 (8.9–11.5) |
13.7 (9.4–18.3) |
0.089 |
12.2 (10.5–14.7) |
11.3 (10.7–17.4) |
2.3 (0.4–4.5) |
−0.4 (−3.1–2.4) |
0.106 |
HF absolute units (mmHg2) |
0.35 (0.24–0.42) |
0.31 (0.18–0.43) |
0.883 |
0.30 (0.21–0.44) |
0.26 (0.16–0.37) |
0.03 (−0.06–0.06) |
−0.06 (−0.14–0.09) |
0.340 |
LF absolute units (mmHg2) |
1.86 (1.53–2.49) |
2.52 (1.55–3.62) |
0.403 |
3.41 (2.99–4.27) |
3.44 (2.34–4.90) |
1.50 (0.72–2.19) |
0.74 (−0.37–2.61) |
0.557 |
HF normalized units (nu) |
0.17 (0.11–0.22) |
0.14 (0.09–0.21) |
0.638 |
0.07 (0.05–0.13) |
0.08 (0.05–0.10) |
−0.05 (−0.08–0.01) |
−0.05 (−0.15–0.01) |
0.454 |
LF normalized units (nu) |
0.83 (0.78–0.89) |
0.86 (0.79–0.91) |
0.638 |
0.93 (0.87–0.95) |
0.92 (0.90–0.95) |
0.05 (0.01–0.08) |
0.05 (0.01–0.15) |
0.454 |
LF/HF | 6.84 (4.20–9.97) |
7.17 (4.62–16.82) |
0.355 | 15.91 (8.02–19.79) |
14.55 (9.77–20.10) |
4.88 (2.21–7.55) |
5.68 (1.47–11.48) |
0.860 |
Wilcoxon-Mann-Whitney’s test. In order to reduce the methodological problem of multiple comparisons, statistical tests were only performed for the cardiovascular variable baseline and Δ (LBNP-Baseline)